3 www.kimr.co.kr

목 차2012 바이오산업 분야별 시장동향과 유망기술 개발전략

Ⅰ. 바이오산업 동향 ··········································································· 311. 바이오산업 분류 정의 ··············································································31

2. 바이오산업 시장동향과 망 ········································································31

1) 바이오산업 국내 매 시장 동향 ········································································35

2) 바이오산업 수출 시장 동향 ··················································································38

3) 바이오산업 수입 시장 동향 ··················································································41

Ⅱ. 바이오의약산업 동향 ··································································· 471. 항생제 시장 동향 ····························································································61

2. 항암제 시장 동향 ····························································································62

3. 백신 시장 동향 ································································································64

4. 호르몬제 시장 동향 ························································································66

5. 면역제제 시장 동향 ························································································68

6. 액제제 시장 동향 ························································································70

7. 성장인자 시장 동향 ························································································72

8. 신개념치료제 시장 동향 ················································································74

9. 진단키트 시장 동향 ························································································76

10. 동물약품 시장 동향 ······················································································78

11. 기타 바이오의약제품 시장 동향 ································································80

Ⅲ. 바이오화학산업 동향 ··································································· 851. 바이오고분자 시장 동향 ················································································98

2. 산업용효소 시약류 시장 동향 ······························································100

3. 연구실험용 효소 시약류 시장 동향 ····················································102

4. 바이오화장품 생활화학제품 시장 동향 ··············································104

5. 바이오농약 비료 시장 동향 ··································································106

6. 기타 바이오화학제품 시장 동향 ································································108

4 한국산업마 연구소

Ⅳ. 바이오식품산업 동향 ································································· 1131. 건강기능식품 시장 동향 ··············································································125

2. 아미노산 시장 동향 ······················································································127

3. 식품첨가물 시장 동향 ··················································································129

4. 발효식품 시장 동향 ······················································································131

5. 사료첨가제 시장 동향 ··················································································133

6. 기타 바이오식품 시장 동향 ········································································135

Ⅴ.바이오환경산업 동향 ··································································· 1411. 환경처리용 미생물제제 시장 동향 ····························································154

2. 미생물 고정화소재 설비 시장 동향 ····················································155

3. 바이오환경제제 시스템 시장 동향 ······················································157

4. 환경오염 측정시스템 시장 동향 ································································159

5. 기타 바이오환경제품 서비스 시장 동향 ············································161

Ⅵ. 바이오전자산업 동향 ································································· 1671. DNA칩 시장 동향 ························································································178

2. 단백질칩 시장 동향 ······················································································180

3. 세포칩 시장 동향 ··························································································182

4. 바이오센서 시장 동향 ··················································································184

5. 바이오멤스 시장 동향 ··················································································186

6. 기타 바이오 자제품 시장 동향 ································································187

Ⅶ. 바이오공정 및 기기산업 동향 ················································· 1931. 바이오반응기 시장 동향 ··············································································205

2. 생체의료기기 진단기 시장 동향 ··························································207

3. 바이오공정 분석기기 시장 동향 ··························································209

4. 공장 공정설계 시장 동향 ······································································211

5. 기타 바이오공정 기기 시장 동향 ························································213

Ⅷ. 바이오에너지 및 자원산업 동향 ············································· 2191. 바이오연료 시장 동향 ··················································································230

2. 인공종자 묘목 시장 동향 ······································································232

3. 실험동물 시장 동향 ······················································································234

5 www.kimr.co.kr

4. 유 자변형 동식물 시장 동향 ····································································236

5. 기타 바이오에 지 자원 시장 동향 ····················································238

Ⅸ. 바이오검정, 정보서비스, 연구개발산업 동향 ······················· 2431. 바이오정보 서비스 시장 동향 ····································································256

2. 유 자 련 분석서비스 시장 동향 ····························································258

3. 단백질 련 분석서비스 시장 동향 ····························································260

4. 연구개발 서비스 시장 동향 ········································································262

5. 바이오안정성 생리활성평가서비스 시장 동향 ··································264

6. 진단 보 서비스 시장 동향 ··································································266

7. 기타 바이오검정, 정보개발서비스 시장 동향 ·········································268

Ⅹ. 유망 바이오시장 및 기술개발 동향 ······································· 2731. 바이오산업 분야별 망과 유망 분야 선정 ············································273

2. 바이오매스에 지 시장과 기술개발 동향 ················································278

1) 바이오매스에 지 시장과 특허 출원 동향 ······················································278

2) 바이오매스에 지 련 기업 일반 황 업실 ····································281

3. 바이오의약품 시장과 기술개발 동향 ························································296

1) 바이오의약품 시장과 특허 출원 동향 ······························································296

2) 바이오의약품 련 기업 일반 황 업실 ············································298

4. 바이오자원, 신소재, 장기 시장과 기술개발 동향 ··································315

1) 바이오자원, 신소재, 장기 시장과 특허 출원 동향 ········································315

2) 바이오자원, 신소재, 장기 련 기업 일반 황 업실 ······················317

5. 메디-바이오진단 시스템 시장과 기술개발 동향 ···································329

1) 메디-바이오진단 시스템 시장과 특허 출원 동향 ·········································329

2) 메디-바이오진단 시스템 련 기업 일반 황 업실 ·······················331

6. 고령친화 의료기기 시장과 기술개발 동향 ··············································341

1) 고령친화 의료기기 시장과 특허 출원 동향 ····················································341

2) 고령친화 의료기기 련 기업 일반 황 업실 ··································343

7. 첨단 상진단기기 시장과 기술개발 동향 ················································355

1) 첨단 상진단기기 시장과 특허 출원 동향 ······················································355

2) 첨단 상진단기기 련 기업 일반 황 업실 ····································357

6 한국산업마 연구소

Ⅺ. 부록 - 유망 바이오 기술 개발 현황 ····································· 3691. 유망 바이오 기술 개발 로드맵 ··································································369

1) 바이오디젤 기술개발 로드맵 ··············································································369

2) 바이오에탄올 기술개발 로드맵 ··········································································370

3) 바이오메스가스 기술개발 로드맵 ······································································371

4) 유 자 재조합 의약품 기술개발 로드맵 ··························································372

5) 세포치료제 기술개발 로드맵 ··············································································373

6) 개량신약 기술개발 로드맵 ··················································································374

7) 천연물의약품 기술개발 로드맵 ··········································································375

8) 바이오화장품 소재 기술개발 로드맵 ································································376

9) 의료용 생체유래소재 기술개발 로드맵 ····························································377

10) 친환경농업소재 기술개발 로드맵 ····································································378

11) 소형 감염성 질환 만성질환 진단기 기술개발 로드맵 ··························379

12) 표 지향 진단 치료용 소재 기술개발 로드맵 ······································381

13) 재활 물리치료기기 기술개발 로드맵 ························································382

14) 인체기능 치제품 기술개발 로드맵 ······························································383

15) 이동지원기기 기술개발 로드맵 ········································································384

16) 생체신호계측기기 기술개발 로드맵 ································································385

17) 유방암 상진단기기 기술개발 로드맵 ··························································386

18) 음 상진단기기 기술개발 로드맵 ··························································388

19) 치과용 상진단기기 기술개발 로드맵 ··························································389

2. 바이오 연구개발 사업 ··················································································390

(1) 키랄의약 바이오의약 제조 품질분석용 키랄칼럼 신소재 개발 ·· 390

(2) 산업용 자 제습기 (바이오 인큐베이터) ·················································390

(3) 작물의 건 육모 토양병해 방효과를 갖는

환경친화형 바이오상토 개발 ········································································390

(4) 스코리아(Scoria) 바이오 필터 개발 ····························································391

(5) 량생산형 화학/바이오 센서 계측기 개발 ·········································391

(6) 바이오좀 공법을 이용한 화장품의 개발 ····················································392

(7) 아세틸콜린효소 치매유발단백질응집 해작용이 있는

생약을 이용한 치매 방 치료효능의 바이오 식품개발 ·····················392

(8) 반도체, 바이오 산업용 순수 제조장치 개발 ········································393

(9) 가 티푸스 억제 신기능 로바이오틱스 미생물 제제개발 ···················393

(10) 토양악화 방지 지력보호용 바이오 비료생산 기술개발 ···················393

(11) 천연 물질이 함유된 생균제 바이오피드의 제조기술 개발 생산 ··· 394

(12) 토양악화 방지 지력보호용 바이오 비료 생산기술 ···························394

7 www.kimr.co.kr

(13) 표면코 처리된 바이오폴리머에 의한 단백질 분리정제용

친화성 크로마토그래피 담체 개발 ····························································395

(14) 식 독균 신속검출용 어 이형 바이오센서 개발 ··································395

(15) 콜라겐을 이용한 바이오 매트릭스 개발 ··················································395

(16) 유방암 련 유용 바이오마커 발굴 진단 소 트웨어 개발 ·············396

(17) 장진단용 뇌/심 계 질환 다지표 바이오센서의 개발 ···················396

(18) 표면 라즈몬공명을 이용한 바이오칩 분석기기의 개발 ······················397

(19) 동충화 를 주원료로 하는 항당뇨 바이오식품의 개발 과학 검증

··························································································································397

(20) 활성탄, 제올라이트 동시 발포 고분자 담체의 개발과 이를 이용한

바이오필터에서의 악취가스 제거 미생물 분포 특성 연구 ·············397

(21) 기능성 바이오 청국장 제품개발 ································································398

(22) 바이오센서를 이용한 무채 당 측정 시스템 개발 ···························398

(23) 아토피질병 억제 신기능 로바이오틱스 산업화 연구 ························398

(24) 건축용 바이오 세라믹 온돌마루 착제 개발 ········································398

(25) 바이오 세라믹이 코 된 주방용품(화이버 쟁반)의 개발 ·····················399

(26) 생화학 오염 방제용 고기능성 나노바이오 신물질개발 ························399

(27) 바이오필터/나노 매 혼성공정을 이용한 고효율 VOC제거기술개발 ···399

(28) AOP 바이오필터에 의한 고농도 질소함유 폐수처리 기술 ············400

(29) Allithiamine이 함유된 바이오 갈릭(bio garlic)의 제조기술 개발 ······ 400

(30) 효소와 시약 극을 이용한 소변검사용 멀티 바이오센서

자동분석장비 개발 ························································································401

(31) 환경친화 공정에 의한 고감성 바이오 타월 개발 ·······························401

(32) 웰빙 / 바이오 산업용 이산화탄소 계측기 련 산업 장치 개발 ····402

(33) 화장품 소재용 실크-나노 골드 바이오 컨쥬 이트의 개발 ··············402

(34) 액상 매와 다단계 바이오필터를 이용한 황화수소

VOCs 동시처리 시스템 개발 ····································································403

(35) Human papillomavirus (HPV) 진단용 PDA 반도체 바이오칩 개발 ··· 403

(36) 유기산 는 복합 로바이오틱 유산균의 생물 환을 이용한

Rg3 함유 인삼 건강 소재 생산 기술 개발 상품화 ·························404

(37) 창상 화상 치유를 진하는 신개념의 바이오 소재 제품화 연구 ··· 404

(38) 하동녹차와 두, 죽염를 이용한 기능성 로바이오틱스의 개발 ······404

(39) 음원을 이용한 바이오필터 제어장치개발 ··············································405

(40) 유동 이 우수한 바이오디젤의 제조방법 ··············································405

(41) 국내산 곡류의 소비 확 를 한 바이오신소재 개발과

그 이용기술개발 ··························································································405

(42) 당측정용 이종 합형 바이오센서 휴 형 측정기 개발 ···············406

8 한국산업마 연구소

(43) 담자균 유래 분해효소의 고농도생산에 의한 바이오식품

의약소재 개발 ······························································································407

(44) 바이오센서 기반의 가축 리를 한 상황인지 미들웨어 기술 개발 ··· 407

(45) 차세 검진 바이오칩 스캐 개발 ··························································408

(46) 고구마의 고기능성 활용 바이오웰빙음료 소재 연구 제품 개발 ·· 409

(47) 극소 액 측정이 가능한 탐침형 이종 합 당측정 바이오센서

시스템 개발 ····································································································409

(48) 바이오 칩의 정 제조를 한 균일한 코 막 형성 가능한

릴 코 기 개발 ······················································································410

(49) 바이오 Glass 발열 을 장착한 램 형 헤어 고데기 개발 ···················411

(50) 바이오마커(CEA, CA 15-3)을 이용한 민감도가 높은

유방암 조기진단키트의 개발 ····································································411

(51) 바이오물질의 메디칼재 박막코 시스템 개발 ····································412

(52) 세포치료제용 골 도성 인젝터블 바이오 스캐폴드 개발 ···················412

(53) 바이오에탄올 생산을 한 에 지 감형 단일 다 식 탈수공정 개발

··························································································································413

(54) 호기발열 처리를 통한 에 지 약형 바이오가스 생산 공정 개발 ·· 414

(55) 곡류발효에 의한 고기능성 로바이오틱 푸드 개발 ···························414

(56) 질량분석용 바이오시료 분리 처리 Kit개발 ·····································416

(57) 미생물센서 기반의 선천성 사이상질환 선별검사용 바이오칩 개발 ·· 417

(58) 노로바이러스의 주요 type들을 인식할 수 있는 conformational epitope

인식 항체 개발 이를 이용한 바이오센서개발 ···································418

(59) 의료용 바이오피드백 스 이로미터-스트 스 분석기 개발 ················419

(60) 새로운 DDS 제제의 개발과 이를 이용한 제품 개발 ····························421

(61) 녹색성장을 한 고농도Biosolid를 이용한 바이오에 지 생산 진

기술개발 ··········································································································421

(62) 바이오가스 고순도메탄 정제 기술 개발 ···········································422

(63) 농산 바이오매스 폐기물을 이용한 자동차용 Trunk System 부품개발·· 422

(64) 뇌졸 환자의 바이오 피드백 운동치료 기술개발 ·······························423

(65) 바이오가스의 고순도 정제를 한 분리막 공정 개발 ·····················423

(66) 합성가스 개질기용 바이오매스 폐기물 가스화로 설계

제작 기술개발 ································································································424

(67) 고온 기소화 음식물쓰 기 탈리액의 바이오가스화 기술 개발 ·····424

(68) 미량 바이오 시료 분석용 다채 분 분석기 개발 ·····························425

(69) 폐자재 바이오 고형연료를 이용한 소형 펠렛 제조 시스템 개발 ··· 426

(70) 이 스캐 기반 고감도 바이오칩 진단기 개발 ·······························426

9 www.kimr.co.kr

(71) 치아우식증 방을 한 로바이오틱 유산균 한방생약소재의

산업화 기술 개발 ··························································································427

(72) 감귤박과 가축분뇨의 혼합 원료를 이용한 지역 바이오매스 맞춤형

기성 소화 시스템 운 기술 개발 ···················································428

(73) Remote Healthcare Monitoring System 개발 (바이오.의료) ··············429

(74) 고부가가치 신기능성 바이오소재 생산시스템의고효율화 ····················429

(75) 바이오디젤 부산물을 이용한 로필 리콜 제조공정 기술개발 ···· 430

(76) 산업폐수 슬러지 재활용 제고를 한 바이오매스 기반

펩타이드계 응집제 제조 기술개발 ··························································430

(77) 바이오피드백 제어형 외 자세지지 시 시스템 개발 ························431

(78) 당질계 바이오에탄올 생산을 한 응집성 효모 발효공정 개발 ···431

(79) 과당화 기술을 이용한 알 -1 안티트립신 바이오베터 개발 ··············432

(80) 바이오 마커 코 스트립 제조 공정 시스템 개발 ·································432

(81) 편백나무로부터 항여드름균, 항비듬균, 항무좀균 활성

미백기능성 바이오소재 개발 ······································································433

(82) 속 방사능 원소 90% 이상 제거 가능한 자원순환형 친환경

바이오필터 ······································································································433

(83) 로바이오틱 유산균 활용, 발효 기술을 이용한 마(산약)의

다이어트 련 기능성화 식품개발 ····························································433

(84) 고해상도 바이오 메디컬 이미징을 한 형 공 미경 개발 ···434

(85) N-말단기 치특이 페길 이션 기술을 활용한 바이오베터 개발

(VEGF-Trap) ·································································································435

(86) 상온유통이 가능한 바이오의약품(단백질, 항체)

약물 달 랫폼 개발 ··················································································436

10 한국산업마 연구소

표 목차2012 바이오산업 분야별 시장동향과 유망기술 개발전략

Ⅰ. 바이오산업 동향 ··········································································· 31[표Ⅰ-1] 바이오산업 시장규모 추이(단 : 백만원) ································································32

[표Ⅰ-2] 바이오산업 분야별 시장규모 추이(단 : 백만원) ··················································34

[표Ⅰ-3] 바이오산업 분야별 국내 매 추이(단 : 백만원) ················································37

[표Ⅰ-4] 바이오산업 분야별 수출 추이(단 : 백만원) ··························································40

[표Ⅰ-5] 바이오산업 분야별 수입 추이(단 : 백만원) ··························································42

Ⅱ. 바이오의약산업 동향 ··································································· 47[표Ⅱ-1] 바이오의약 주력 기업 추이 (단 : 개, %) ······························································47

[표Ⅱ-2] 바이오의약 주력 기업 지역별 분포 추이 (단 : 개) ············································48

[표Ⅱ-3] 바이오의약 주력 기업의 인력 황 추이 (단 : 명) ··············································49

[표Ⅱ-4] 바이오의약 주력 기업의 연구개발비 추이 (단 : 백만원, %) ····························49

[표Ⅱ-5] 바이오의약 주력 기업의 시설투자비 추이 (단 : 백만원, %) ····························49

[표Ⅱ-6] 바이오의약품 시장규모 추이 (단 : 백만원) ··························································50

[표Ⅱ-7] 바이오의약품 품목별 시장규모 추이 (단 : 백만원) ············································52

[표Ⅱ-8] 바이오의약품 품목별 국내 매 추이 (단 : 백만원) ··········································54

[표Ⅱ-9] 바이오의약품 품목별 수출 추이 (단 : 백만원) ····················································57

[표Ⅱ-10] 바이오의약품 품목별 수입 추이 (단 : 백만원) ··················································59

[표Ⅱ-11] 항생제 시장규모 추이 (단 : 백만원) ····································································62

[표Ⅱ-12] 항암제 시장규모 추이 (단 : 백만원) ····································································63

[표Ⅱ-13] 백신 시장규모 추이 (단 : 백만원) ········································································65

[표Ⅱ-14] 호르몬제 시장규모 추이 (단 : 백만원) ································································67

[표Ⅱ-15] 면역제제 시장규모 추이 (단 : 백만원) ································································69

[표Ⅱ-16] 액제제 시장규모 추이 (단 : 백만원) ································································71

[표Ⅱ-17] 성장인자 시장규모 추이 (단 : 백만원) ································································73

[표Ⅱ-18] 신개념치료제 시장규모 추이 (단 : 백만원) ························································75

[표Ⅱ-19] 진단키트 시장규모 추이 (단 : 백만원) ································································77

[표Ⅱ-20] 동물약품 시장규모 추이 (단 : 백만원) ································································79

[표Ⅱ-21] 기타 바이오의약제품 시장규모 추이 (단 : 백만원) ··········································81

11 www.kimr.co.kr

Ⅲ. 바이오화학산업 동향 ··································································· 85[표Ⅲ-1] 바이오화학 주력 기업 추이 (단 : 개, %) ······························································85

[표Ⅲ-2] 바이오화학 주력 기업 지역별 분포 추이 (단 : 개) ············································86

[표Ⅲ-3] 바이오화학 주력 기업의 인력 황 추이 (단 : 명) ··············································86

[표Ⅲ-4] 바이오화학 주력 기업의 연구개발비 추이 (단 : 백만원, %) ····························87

[표Ⅲ-5] 바이오화학 주력 기업의 시설투자비 추이 (단 : 백만원, %) ····························87

[표Ⅲ-6] 바이오화학 시장규모 추이 (단 : 백만원) ······························································88

[표Ⅲ-7] 바이오화학 품목별 시장규모 추이 (단 : 백만원) ················································90

[표Ⅲ-8] 바이오화학 품목별 국내 매 추이 (단 : 백만원) ··············································92

[표Ⅲ-9] 바이오화학 품목별 수출 추이 (단 : 백만원) ························································95

[표Ⅲ-10] 바이오화학 품목별 수입 추이 (단 : 백만원) ······················································97

[표Ⅲ-11] 바이오고분자 시장규모 추이 (단 : 백만원) ························································99

[표Ⅲ-12] 산업용효소 시약류 시장규모 추이 (단 : 백만원) ······································101

[표Ⅲ-13] 연구실험용 효소 시약류 시장규모 추이 (단 : 백만원) ····························103

[표Ⅲ-14] 바이오화장품 생활화학제품 시장규모 추이 (단 : 백만원) ······················105

[표Ⅲ-15] 바이오농약 비료 시장규모 추이 (단 : 백만원) ··········································107

[표Ⅲ-16] 기타 바이오화학제품 시장규모 추이 (단 : 백만원) ········································109

Ⅳ. 바이오식품산업 동향 ································································· 113[표Ⅳ-1] 바이오식품 주력 기업 추이 (단 : 개, %) ····························································113

[표Ⅳ-2] 바이오식품 주력 기업 지역별 분포 추이 (단 : 개) ··········································114

[표Ⅳ-3] 바이오식품 주력 기업의 인력 황 추이 (단 : 명) ············································114

[표Ⅳ-4] 바이오식품 주력 기업의 연구개발비 추이 (단 : 백만원, %) ··························115

[표Ⅳ-5] 바이오식품 주력 기업의 시설투자비 추이 (단 : 백만원, %) ··························115

[표Ⅳ-6] 바이오식품 시장규모 추이 (단 : 백만원) ····························································116

[표Ⅳ-7] 바이오식품 품목별 시장규모 추이 (단 : 백만원) ··············································118

[표Ⅳ-8] 바이오식품 품목별 국내 매 추이 (단 : 백만원) ············································120

[표Ⅳ-9] 바이오식품 품목별 수출 추이 (단 : 백만원) ······················································122

[표Ⅳ-10] 바이오식품 품목별 수입 추이 (단 : 백만원) ····················································124

[표Ⅳ-11] 건강기능식품 시장규모 추이 (단 : 백만원) ······················································126

[표Ⅳ-12] 아미노산 시장규모 추이 (단 : 백만원) ······························································128

[표Ⅳ-13] 식품첨가물 시장규모 추이 (단 : 백만원) ··························································130

[표Ⅳ-14] 발효식품 시장규모 추이 (단 : 백만원) ······························································132

[표Ⅳ-15] 사료첨가제 시장규모 추이 (단 : 백만원) ··························································134

[표Ⅳ-16] 기타 바이오식품 시장규모 추이 (단 : 백만원) ················································136

12 한국산업마 연구소

Ⅴ.바이오환경산업 동향 ··································································· 141[표Ⅴ-1] 바이오환경 주력 기업 추이 (단 : 개, %) ····························································141

[표Ⅴ-2] 바이오환경 주력 기업 지역별 분포 추이 (단 : 개) ··········································142

[표Ⅴ-3] 바이오환경 주력 기업의 인력 황 추이 (단 : 명) ············································142

[표Ⅴ-4] 바이오환경 주력 기업의 연구개발비 추이 (단 : 백만원, %) ··························143

[표Ⅴ-5] 바이오환경 주력 기업의 시설투자비 추이 (단 : 백만원, %) ··························143

[표Ⅴ-6] 바이오환경 시장규모 추이 (단 : 백만원) ····························································144

[표Ⅴ-7] 바이오환경 품목별 시장규모 추이 (단 : 백만원) ··············································146

[표Ⅴ-8] 바이오환경 품목별 국내 매 추이 (단 : 백만원) ············································148

[표Ⅴ-9] 바이오환경 품목별 수출 추이 (단 : 백만원) ······················································151

[표Ⅴ-10] 바이오환경 품목별 수입 추이 (단 : 백만원) ····················································153

[표Ⅴ-11] 환경처리용 미생물제제 시장규모 추이 (단 : 백만원) ····································155

[표Ⅴ-12] 미생물 고정화소재 설비 시장규모 추이 (단 : 백만원) ····························156

[표Ⅴ-13] 바이오환경제제 시스템 시장규모 추이 (단 : 백만원) ······························158

[표Ⅴ-14] 환경오염 측정시스템 시장규모 추이 (단 : 백만원) ········································160

[표Ⅴ-15] 기타 바이오환경제품 서비스 시장규모 추이 (단 : 백만원) ····················162

Ⅵ. 바이오전자산업 동향 ································································· 167[표Ⅵ-1] 바이오 자 주력 기업 추이 (단 : 개, %) ····························································167

[표Ⅵ-2] 바이오 자 주력 기업 지역별 분포 추이 (단 : 개) ··········································168

[표Ⅵ-3] 바이오 자 주력 기업의 인력 황 추이 (단 : 명) ············································168

[표Ⅵ-4] 바이오 자 주력 기업의 연구개발비 추이 (단 : 백만원, %) ··························169

[표Ⅵ-5] 바이오 자 주력 기업의 시설투자비 추이 (단 : 백만원, %) ··························169

[표Ⅵ-6] 바이오 자 시장규모 추이 (단 : 백만원) ····························································170

[표Ⅵ-7] 바이오 자 품목별 시장규모 추이 (단 : 백만원) ··············································172

[표Ⅵ-8] 바이오 자 품목별 국내 매 추이 (단 : 백만원) ············································173

[표Ⅵ-9] 바이오 자 품목별 수출 추이 (단 : 백만원) ······················································176

[표Ⅵ-10] 바이오 자 품목별 수입 추이 (단 : 백만원) ····················································177

[표Ⅵ-11] DNA칩 시장규모 추이 (단 : 백만원) ·································································179

[표Ⅵ-12] 단백질칩 시장규모 추이 (단 : 백만원) ······························································181

[표Ⅵ-13] 세포칩 시장규모 추이 (단 : 백만원) ··································································183

[표Ⅵ-14] 바이오센서 시장규모 추이 (단 : 백만원) ··························································185

[표Ⅵ-15] 바이오멤스 시장규모 추이 (단 : 백만원) ··························································186

[표Ⅵ-16] 기타바이오 자제품 시장규모 추이 (단 : 백만원) ··········································188

Ⅶ. 바이오공정 및 기기산업 동향 ················································· 193[표Ⅶ-1] 바이오공정 기기 주력 기업 추이 (단 : 개, %) ············································193

[표Ⅶ-2] 바이오공정 기기 주력 기업 지역별 분포 추이 (단 : 개) ··························194

[표Ⅶ-3] 바이오공정 기기 주력 기업의 인력 황 추이 (단 : 명) ····························194

[표Ⅶ-4] 바이오공정 기기 주력 기업의 연구개발비 추이 (단 : 백만원, %) ··········195

13 www.kimr.co.kr

[표Ⅶ-5] 바이오공정 기기 주력 기업의 시설투자비 추이 (단 : 백만원, %) ··········195

[표Ⅶ-6] 바이오공정 기기 시장규모 추이 (단 : 백만원) ············································196

[표Ⅶ-7] 바이오공정 기기 품목별 시장규모 추이 (단 : 백만원) ······························198

[표Ⅶ-8] 바이오공정 기기 품목별 국내 매 추이 (단 : 백만원) ····························200

[표Ⅶ-9] 바이오공정 기기 품목별 수출 추이 (단 : 백만원) ······································202

[표Ⅶ-10] 바이오공정 기기 품목별 수입 추이 (단 : 백만원) ····································204

[표Ⅶ-11] 바이오반응기 시장규모 추이 (단 : 백만원) ······················································206

[표Ⅶ-12] 생체의료기기 진단기 시장규모 추이 (단 : 백만원) ··································208

[표Ⅶ-13] 바이오공정 분석기기 시장규모 추이 (단 : 백만원) ··································210

[표Ⅶ-14] 공장 공정설계 시장규모 추이 (단 : 백만원) ··············································212

[표Ⅶ-15] 기타 바이오공정 기기 시장규모 추이 (단 : 백만원) ································214

Ⅷ. 바이오에너지 및 자원산업 동향 ············································· 219[표Ⅷ-1] 바이오에 지 자원 주력 기업 추이 (단 : 개, %) ········································219

[표Ⅷ-2] 바이오에 지 자원 주력 기업 지역별 분포 추이 (단 : 개) ······················220

[표Ⅷ-3] 바이오에 지 자원 주력 기업의 인력 황 추이 (단 : 명) ························220

[표Ⅷ-4] 바이오에 지 자원 주력 기업의 연구개발비 추이 (단 : 백만원, %) ······221

[표Ⅷ-5] 바이오에 지 자원 주력 기업의 시설투자비 추이 (단 : 백만원, %) ······221

[표Ⅷ-6] 바이오에 지 자원 시장규모 추이 (단 : 백만원) ········································222

[표Ⅷ-7] 바이오에 지 자원 품목별 시장규모 추이 (단 : 백만원) ··························224

[표Ⅷ-8] 바이오에 지 자원 품목별 국내 매 추이 (단 : 백만원) ························226

[표Ⅷ-9] 바이오에 지 자원 품목별 수출 추이 (단 : 백만원) ··································228

[표Ⅷ-10] 바이오에 지 자원 품목별 수입 추이 (단 : 백만원) ································229

[표Ⅷ-11] 바이오연료 시장규모 추이 (단 : 백만원) ··························································231

[표Ⅷ-12] 인공종자 묘목 시장규모 추이 (단 : 백만원) ··············································233

[표Ⅷ-13] 실험동물 시장규모 추이 (단 : 백만원) ······························································235

[표Ⅷ-14] 유 자변형 동식물 시장규모 추이 (단 : 백만원) ············································237

[표Ⅷ-15] 기타 바이오에 지 자원 시장규모 추이 (단 : 백만원) ····························239

Ⅸ. 바이오검정, 정보서비스, 연구개발산업 동향 ······················· 243[표Ⅸ-1] 바이오검정, 정보서비스 연구개발 주력 기업 추이 (단 : 개, %) ···················· 243

[표Ⅸ-2] 바이오검정, 정보서비스 연구개발 주력 기업 지역별 분포 추이 (단 : 개) ···· 244

[표Ⅸ-3] 바이오검정, 정보서비스 연구개발 주력 기업의 인력 황 추이 (단 : 명) ······ 245

[표Ⅸ-4] 바이오검정, 정보서비스, 연구개발 주력기업의 연구개발비 추이 (단 : 백만원, %) ·· 245

[표Ⅸ-5] 바이오검정, 정보서비스, 연구개발 주력기업의 시설투자비 추이 (단 : 백만원, %) ·· 245

[표Ⅸ-6] 바이오검정, 정보서비스 연구개발품 시장규모 추이 (단 : 백만원) ················· 246

[표Ⅸ-7] 바이오검정, 정보서비스 연구개발 품목별 시장규모 추이 (단 : 백만원) ········ 248

[표Ⅸ-8] 바이오검정, 정보서비스 연구개발 품목별 국내 매 추이 (단 : 백만원) ······ 251

[표Ⅸ-9] 바이오검정, 정보서비스 연구개발 품목별 수출 추이 (단 : 백만원) ··············· 254

[표Ⅸ-10] 바이오검정, 정보서비스 연구개발품 품목별 수입 추이 (단 : 백만원) ·········· 255

14 한국산업마 연구소

[표Ⅸ-11] 바이오정보 서비스 시장규모 추이 (단 : 백만원) ·················································· 257

[표Ⅸ-12] 유 자 련 분석서비스 시장규모 추이 (단 : 백만원) ··········································· 259

[표Ⅸ-13] 단백질 련 분석서비스 시장규모 추이 (단 : 백만원) ··········································· 261

[표Ⅸ-14] 연구개발 서비스 시장규모 추이 (단 : 백만원) ······················································ 263

[표Ⅸ-15] 바이오안정성 생리활성평가서비스 시장규모 추이 (단 : 백만원) ·················· 265

[표Ⅸ-16] 진단 보 서비스 시장규모 추이 (단 : 백만원) ················································ 267

[표Ⅸ-17] 기타 바이오검정, 정보개발서비스 연구개발 시장규모 추이 (단 : 백만원) ·· 269

Ⅹ. 유망 바이오시장 및 기술개발 동향 ······································· 273[표Ⅹ-1] 바이오산업 분야별 망 (단 : 억원, %) ······························································275

[표Ⅹ-2] 이피엑스그린 미칼(주) 기업 황 업 실 ···········································281

[표Ⅹ-3] 상(주) 기업 황 업 실 ···········································································282

[표Ⅹ-4] (주) 우건설 기업 황 업 실 ···································································282

[표Ⅹ-5] (주)동부한농 기업 황 업 실 ···································································283

[표Ⅹ-6] (주)두원정공 기업 황 업 실 ···································································284

[표Ⅹ-7] (주)바이오트론 기업 황 업 실 ·······························································284

[표Ⅹ-8] 삼성물산(주) 기업 황 업 실 ···································································285

[표Ⅹ-9] (주)에코에 지홀딩스 기업 황 업 실 ···················································285

[표Ⅹ-10] 서 주정(주) 기업 황 업 실 ·································································286

[표Ⅹ-11] 애경유화(주) 기업 황 업 실 ·································································287

[표Ⅹ-12] (주)에코솔루션 기업 황 업 실 ·····························································287

[표Ⅹ-13] (주)엠에 지 기업 황 업 실 ·································································288

[표Ⅹ-14] 일산실업(주) 기업 황 업 실 ·································································289

[표Ⅹ-15] 제이씨 미칼(주) 기업 황 업 실 ·························································289

[표Ⅹ-16] (주)지앤지인텍 기업 황 업 실 ·····························································290

[표Ⅹ-17] (주)진로발효 기업 황 업 실 ·································································290

[표Ⅹ-18] (주)창해에탄올 기업 황 업 실 ·····························································291

[표Ⅹ-19] 코오롱 로벌(주) 기업 황 업 실 ·························································292

[표Ⅹ-20] (주)포스코 기업 황 업 실 ·····································································292

[표Ⅹ-21] 한라건설(주) 기업 황 업 실 ·································································293

[표Ⅹ-22] (주)비디 이 기업 황 업 실 ·································································294

[표Ⅹ-23] 지에스건설(주) 기업 황 업 실 ·····························································294

[표Ⅹ-24] 지에스칼텍스(주) 기업 황 업 실 ·························································295

[표Ⅹ-25] SK에 지(주) 기업 황 업 실 ································································295

[표Ⅹ-26] 구주제약(주) 기업 황 업 실 ·································································299

[표Ⅹ-27] 근화제약(주) 기업 황 업 실 ·································································299

[표Ⅹ-28] (주)녹십자 기업 황 업 실 ·····································································300

[표Ⅹ-29] 동아제약(주) 기업 황 업 실 ·································································301

[표Ⅹ-30] 메디포스트(주) 기업 황 업 실 ·····························································301

[표Ⅹ-31] (주)바이넥스 기업 황 업 실 ·································································302

[표Ⅹ-32] (주)바이로메드 기업 황 업 실 ·····························································303

15 www.kimr.co.kr

[표Ⅹ-33] (주)바이오톡스텍 기업 황 업 실 ·························································303

[표Ⅹ-34] 부 약품(주) 기업 황 업 실 ·································································304

[표Ⅹ-35] (주)서울제약 기업 황 업 실 ·································································305

[표Ⅹ-36] 세원셀론텍(주) 기업 황 업 실 ·····························································305

[표Ⅹ-37] (주)셀트리온 기업 황 업 실 ·································································306

[표Ⅹ-38] (주)아미팜 기업 황 업 실 ·····································································307

[표Ⅹ-39] 안국약품(주) 기업 황 업 실 ·································································307

[표Ⅹ-40] (주)앱자인 기업 황 업 실 ·····································································308

[표Ⅹ-41] (주)이노셀 기업 황 업 실 ·····································································308

[표Ⅹ-42] 일동제약(주) 기업 황 업 실 ·································································309

[표Ⅹ-43] (주)제넥신 기업 황 업 실 ·····································································310

[표Ⅹ-44] (주)종근당 기업 황 업 실 ·····································································310

[표Ⅹ-45] 제이더블유 외제약(주) 기업 황 업 실 ·············································311

[표Ⅹ-46] 크리스탈지노믹스(주) 기업 황 업 실 ·················································312

[표Ⅹ-47] 한화 미칼(주) 기업 황 업 실 ·····························································312

[표Ⅹ-48] (주)에이앤씨바이오 기업 황 업 실 ·····················································313

[표Ⅹ-49] (주)엘지생명과학 기업 황 업 실 ·························································314

[표Ⅹ-50] (주)그린바이오텍 기업 황 업 실 ·························································317

[표Ⅹ-51] (주)그린 미칼 기업 황 업 실 ·····························································317

[표Ⅹ-52] (주)나이벡 기업 황 업 실 ·····································································318

[표Ⅹ-53] (주)동부한농 기업 황 업 실 ·································································318

[표Ⅹ-54] (주)라이 코드 기업 황 업 실 ·····························································319

[표Ⅹ-55] (주)옵티팜솔루션 기업 황 업 실 ·························································320

[표Ⅹ-56] (주)바이오랜드 기업 황 업 실 ·····························································320

[표Ⅹ-57] 바이오스펙트럼(주) 기업 황 업 실 ·····················································321

[표Ⅹ-58] (주)슈가버블 기업 황 업 실 ·································································321

[표Ⅹ-59] (주)아모 퍼시픽 기업 황 업 실 ·························································322

[표Ⅹ-60] (주)엠젠 기업 황 업 실 ·········································································322

[표Ⅹ-61] (주)올메디쿠스 기업 황 업 실 ·····························································323

[표Ⅹ-62] (주)인트론바이오테크놀로지 기업 황 업 실 ·····································323

[표Ⅹ-63] 조아제약(주) 기업 황 업 실 ·································································324

[표Ⅹ-64] (주)코리아본뱅크 기업 황 업 실 ·························································325

[표Ⅹ-65] (주)휴비스 기업 황 업 실 ·····································································325

[표Ⅹ-66] 씨제이제일제당(주) 기업 황 업 실 ·····················································326

[표Ⅹ-67] (주)엘지생활건강 기업 황 업 실 ·························································327

[표Ⅹ-68] (주)한국로슈 기업 황 업 실 ·································································327

[표Ⅹ-69] 굿젠(주) 기업 황 업 실 ·········································································331

[표Ⅹ-70] 나루다이텍(주) 기업 황 업 실 ·····························································331

[표Ⅹ-71] (주)녹십자 기업 황 업 실 ·····································································332

[표Ⅹ-72] 동아제약(주) 기업 황 업 실 ·································································333

[표Ⅹ-73] (주)마크로젠 기업 황 업 실 ·································································333

16 한국산업마 연구소

[표Ⅹ-74] 바디텍메드(주) 기업 황 업 실 ·····························································334

[표Ⅹ-75] (주)바이오니아 기업 황 업 실 ·····························································334

[표Ⅹ-76] (주)바이오메드랩 기업 황 업 실 ·························································335

[표Ⅹ-77] 삼성 자(주) 기업 황 업 실 ·································································336

[표Ⅹ-78] (주)씨젠 기업 황 업 실 ·········································································336

[표Ⅹ-79] (주)아이센스 기업 황 업 실 ·································································337

[표Ⅹ-80] (주)아이소텍 기업 황 업 실 ·································································338

[표Ⅹ-81] (주)에스디 기업 황 업 실 ·····································································338

[표Ⅹ-82] (주)올메디쿠스 기업 황 업 실 ·····························································339

[표Ⅹ-83] (주)인포피아 기업 황 업 실 ·································································339

[표Ⅹ-84] (주)지노믹트리 기업 황 업 실 ·····························································340

[표Ⅹ-85] (주)엘지생명과학 기업 황 업 실 ·························································340

[표Ⅹ-86] (주)건융아이비씨 기업 황 업 실 ·························································343

[표Ⅹ-87] 성공업(주) 기업 황 업 실 ·································································344

[표Ⅹ-88] (주) 성마리 기업 황 업 실 ·····························································345

[표Ⅹ-89] 요메디(주) 기업 황 업 실 ·································································345

[표Ⅹ-90] 한보청기(주) 기업 황 업 실 ·····························································346

[표Ⅹ-91] (주)메디아나 기업 황 업 실 ·································································346

[표Ⅹ-92] (주)미건의료기 기업 황 업 실 ·····························································347

[표Ⅹ-93] (주)바이오넷 기업 황 업 실 ·································································347

[표Ⅹ-94] (주)비트컴퓨터 기업 황 업 실 ·····························································348

[표Ⅹ-95] (주)삼주유니콘 기업 황 업 실 ·····························································349

[표Ⅹ-96] (주)성우특장 기업 황 업 실 ·································································349

[표Ⅹ-97] (주)솔고바이오메디칼 기업 황 업 실 ·················································349

[표Ⅹ-98] (주)스타키코리아 기업 황 업 실 ·························································350

[표Ⅹ-99] (주)썸텍 기업 황 업 실 ·········································································351

[표Ⅹ-100] (주)엔텍 기업 황 업 실 ·······································································351

[표Ⅹ-101] (주)유비 어 기업 황 업 실 ·······························································352

[표Ⅹ-102] (주)코 텍 기업 황 업 실 ···································································352

[표Ⅹ-103] (주)퓨런메디칼 기업 황 업 실 ···························································353

[표Ⅹ-104] (주)한국보청기 기업 황 업 실 ···························································353

[표Ⅹ-105] (주)휴 기업 황 업 실 ···································································354

[표Ⅹ-106] (주)휴비딕 기업 황 업 실 ···································································354

[표Ⅹ-107] (주)디알텍 기업 황 업 실 ···································································357

[표Ⅹ-108] (주)리스템 기업 황 업 실 ···································································358

[표Ⅹ-109] 메디퓨처(주) 기업 황 업 실 ·······························································358

[표Ⅹ-110] (주)바이오넷 기업 황 업 실 ·······························································359

[표Ⅹ-111] (주)바텍 기업 황 업 실 ·······································································359

[표Ⅹ-112] 삼성모바일디스 이(주) 기업 황 업 실 ·······································360

[표Ⅹ-113] (주)사이버메드 기업 황 업 실 ···························································361

[표Ⅹ-114] (주)세 엔디씨 기업 황 업 실 ···························································361

17 www.kimr.co.kr

[표Ⅹ-115] (주)휴먼스캔 기업 황 업 실 ·······························································361

[표Ⅹ-116] (주)에코 이 기업 황 업 실 ·······························································362

[표Ⅹ-117] (주)에코트론 기업 황 업 실 ·······························································362

[표Ⅹ-118] (주)정원정 기업 황 업 실 ·······························································363

[표Ⅹ-119] (주)제노 이 기업 황 업 실 ·······························································363

[표Ⅹ-120] (주)제이더블유 외메디칼 기업 황 업 실 ·······································364

[표Ⅹ-121] 지멘스(주) 기업 황 업 실 ···································································364

[표Ⅹ-122] (주)포스콤 기업 황 업 실 ···································································365

[표Ⅹ-123] (주)피제이 자 기업 황 업 실 ···························································366

[표Ⅹ-124] (주) 의료기기 기업 황 업 실 ·······················································366

Ⅺ. 부록 - 유망 바이오 기술 개발 현황 ····································· 369[표Ⅺ-1] 바이오디젤 핵심요소기술 연구 목표 ······································································369

[표Ⅺ-2] 바이오에탄올 핵심요소기술 연구 목표 ··································································370

[표Ⅺ-3] 바이오매스가스 핵심요소기술 연구 목표 ······························································371

[표Ⅺ-4] 유 자 재조합 의약품 핵심요소기술 연구 목표 ··················································372

[표Ⅺ-5] 세포치료제 핵심요소기술 연구 목표 ······································································373

[표Ⅺ-6] 개량신약 핵심요소기술 연구 목표 ··········································································374

[표Ⅺ-7] 천연물의약품 핵심요소기술 연구 목표 ··································································375

[표Ⅺ-8] 바이오화장품 소재 핵심요소기술 연구 목표 ························································376

[표Ⅺ-9] 의료용 생체유래소재 핵심요소기술 연구 목표 ····················································377

[표Ⅺ-10] 친환경농업소재 핵심요소기술 연구 목표 ····························································378

[표Ⅺ-11] 소형 감염성 질환 만성질환 진단기 핵심요소기술 연구 목표 ··················379

[표Ⅺ-12] 표 지향 진단 치료용 소재 핵심요소기술 연구 목표 ······························381

[표Ⅺ-13] 재활 물리치료기기 핵심요소기술 연구 목표 ················································382

[표Ⅺ-14] 이동지원기기 핵심요소기술 연구 목표 ································································383

[표Ⅺ-15] 이동지원기기 핵심요소기술 연구 목표 ································································384

[표Ⅺ-16] 생체신호계측기기 핵심요소기술 연구 목표 ························································385

[표Ⅺ-17] 유방암 상진단기기 핵심요소기술 연구 목표 ··················································386

[표Ⅺ-18] 음 상진단기기 핵심요소기술 연구 목표 ··················································388

[표Ⅺ-19] 치과용 상진단기기 핵심요소기술 연구 목표 ··················································389

[표Ⅺ-20] 키랄의약 바이오의약 제조 품질분석용 키랄칼럼 신소재 개발 사업 개요 ························ 390

[표Ⅺ-21] 산업용 자 제습기 (바이오 인큐베이터) 개발 사업 개요 ······················································· 390

[표Ⅺ-22] 작물의 건 육모 토양병해 방효과를 갖는 환경친화형 바이오상토 개발 사업 개요 ··········· 390

[표Ⅺ-23] 스코리아(Scoria) 바이오 필터 개발 사업 개요 ········································································ 391

[표Ⅺ-24] 량생산형 화학/바이오 센서 계측기 개발 사업 개요 ························································· 391

[표Ⅺ-25] 바이오좀 공법을 이용한 화장품의 개발 사업 개요 ·································································· 392

[표Ⅺ-26] 아세틸콜린효소 치매유발단백질응집 해작용이 있는 생약을 이용한 치매 방

치료효능의 바이오 식품개발 사업 개요 ·················································································· 392

[표Ⅺ-27] 반도체, 바이오 산업용 순수 제조장치 개발 사업 개요 ························································· 393

[표Ⅺ-28] 가 티푸스 억제 신기능 로바이오틱스 미생물 제제개발 사업 개요 ······································· 393

18 한국산업마 연구소

[표Ⅺ-29] 토양악화 방지 지력보호용 바이오 비료생산 기술개발 사업 개요 ········································ 393

[표Ⅺ-30] 천연 물질이 함유된 생균제 바이오피드의 제조기술 개발 생산 사업 개요 ·························· 394

[표Ⅺ-31] 토양악화 방지 지력보호용 바이오 비료 생산기술 사업 개요 ··············································· 394

[표Ⅺ-32] 표면코 처리된 바이오폴리머에 의한 단백질 분리정제용 친화성 크로마토그래피 담체개발

사업 개요 ····························································································································· 395

[표Ⅺ-33] 식 독균 신속검출용 어 이형 바이오센서 개발 사업 개요 ····················································· 395

[표Ⅺ-34] 콜라겐을 이용한 바이오 매트릭스 개발 사업 개요 ·································································· 395

[표Ⅺ-35] 유방암 련 유용 바이오마커 발굴 진단 소 트웨어 개발 사업 개요 ··································· 396

[표Ⅺ-36] 장진단용 뇌/심 계 질환 다지표 바이오센서의 개발 사업 개요 ········································· 396

[표Ⅺ-37] 표면 라즈몬공명을 이용한 바이오칩 분석기기의 개발 사업 개요 ··········································· 397

[표Ⅺ-38] 동충화 를 주원료로 하는 항당뇨 바이오식품의 개발 과학 검증 개발 사업 개요 ············· 397

[표Ⅺ-39] 활성탄, 제올라이트 동시 발포 고분자 담체의 개발과 이를 이용한 바이오필터에서의 악취가스 제거

미생물 분포 특성 연구 개발 사업 개요 ············································································· 397

[표Ⅺ-40] 기능성 바이오 청국장 제품개발 사업 개요 ············································································· 398

[표Ⅺ-41] 바이오센서를 이용한 무채 당 측정 시스템 개발 사업 개요 ··············································· 398

[표Ⅺ-42] 아토피질병 억제 신기능 로바이오틱스 산업화 연구 개발 사업 개요 ····································· 398

[표Ⅺ-43] 건축용 바이오 세라믹 온돌마루 착제 개발 사업 개요 ·························································· 398

[표Ⅺ-44] 바이오 세라믹이 코 된 주방용품(화이버 쟁반)의 개발 사업 개요 ··········································· 399

[표Ⅺ-45] 생화학 오염 방제용 고기능성 나노바이오 신물질개발 사업 개요 ············································· 399

[표Ⅺ-46] 바이오필터/나노 매 혼성공정을 이용한 고효율 VOC제거기술개발 사업 개요 ·························· 399

[표Ⅺ-47] AOP 바이오필터에 의한 고농도 질소함유 폐수처리 기술 개발 사업 개요 ··························· 400

[표Ⅺ-48] Allithiamine이 함유된 바이오 갈릭(bio garlic)의 제조기술 개발 사업 개요 ······························ 400

[표Ⅺ-49] 효소와 시약 극을 이용한 소변검사용 멀티 바이오센서 자동분석장비 개발 사업 개요 ········ 401

[표Ⅺ-50] 환경친화 공정에 의한 고감성 바이오 타월 개발 사업 개요 ·················································· 401

[표Ⅺ-51] 웰빙 / 바이오 산업용 이산화탄소 계측기 련 산업 장치 개발 사업 개요 ·························· 402

[표Ⅺ-52] 화장품 소재용 실크-나노 골드 바이오 컨쥬 이트의 개발 사업 개요 ······································ 402

[표Ⅺ-53] 액상 매와 다단계 바이오필터를 이용한 황화수소 VOCs 동시처리 시스템 개발사업 개요 ··· 403

[표Ⅺ-54] Human papillomavirus (HPV) 진단용 PDA 반도체 바이오칩 개발 사업 개요 ·························· 403

[표Ⅺ-55] 유기산 는 복합 로바이오틱 유산균의 생물 환을 이용한 Rg3 함유 인삼 건강 소재 생산

기술 개발 상품화 개발 사업 개요 ····················································································· 404

[표Ⅺ-56] 창상 화상 치유를 진하는 신개념의 바이오 소재 제품화 연구 개발 사업 개요 ·················· 404

[표Ⅺ-57] 하동녹차와 두, 죽염를 이용한 기능성 로바이오틱스의 개발 사업 개요 ······························ 404

[표Ⅺ-58] 음원을 이용한 바이오필터 제어장치개발 사업 개요 ································································ 405

[표Ⅺ-59] 유동 이 우수한 바이오디젤의 제조방법 개발 사업 개요 ························································ 405

[표Ⅺ-60] 국내산 곡류의 소비 확 를 한 바이오신소재 개발과 그 이용기술개발 사업 개요 ········ 405

[표Ⅺ-61] 당측정용 이종 합형 바이오센서 휴 형 측정기 개발 사업 개요 ····································· 406

[표Ⅺ-62] 담자균 유래 분해효소의 고농도생산에 의한 바이오식품 의약소재 개발 사업 개요 ········ 407

[표Ⅺ-63] 바이오센서 기반의 가축 리를 한 상황인지 미들웨어 기술 개발 사업 개요 ·························· 407

[표Ⅺ-64] 차세 검진 바이오칩 스캐 개발 사업 개요 ········································································ 408

[표Ⅺ-65] 고구마의 고기능성 활용 바이오 웰빙음료 소재 연구 제품 개발 사업 개요 ······················· 409

[표Ⅺ-66] 극소 액 측정이 가능한 탐침형 이종 합 당측정 바이오센서 시스템 개발 사업 개요 ··········· 409

19 www.kimr.co.kr

[표Ⅺ-67] 바이오 칩의 정 제조를 한 균일한 코 막 형성 가능한 릴 코 기 개발 사업 개요 ········ 410

[표Ⅺ-68] 바이오 Glass 발열 을 장착한 램 형 헤어 고데기 개발 사업 개요 ········································ 411

[표Ⅺ-69] 바이오마커(CEA, CA 15-3)을 이용한 민감도가 높은 유방암 조기진단키트의 개발 사업 개요 ··· 411

[표Ⅺ-70] 바이오물질의 메디칼재 박막코 시스템 개발 사업 개요 ························································ 412

[표Ⅺ-71] 세포치료제용 골 도성 인젝터블 바이오 스캐폴드 개발 사업 개요 ·········································· 412

[표Ⅺ-72] 바이오에탄올 생산을 한 에 지 감형 단일 다 식 탈수공정 개발 사업 개요 ·················· 413

[표Ⅺ-73] 호기발열 처리를 통한 에 지 약형 바이오가스 생산 공정 개발 사업 개요 ························ 414

[표Ⅺ-74] 곡류발효에 의한 고기능성 로바이오틱 푸드 개발 사업 개요 ················································ 414

[표Ⅺ-75] 질량분석용 바이오시료 분리 처리 Kit개발 사업 개요 ························································· 416

[표Ⅺ-76] 미생물센서 기반의 선천성 사이상질환 선별검사용 바이오칩 개발 사업 개요 ························ 417

[표Ⅺ-77] 노로바이러스의 주요 type들을 인식할 수 있는 conformational epitope 인식 항체 개발

이를 이용한 바이오센서개발 사업 개요 ·················································································· 418

[표Ⅺ-78] 의료용 바이오피드백 스 이로미터-스트 스 분석기 개발 사업 개요 ······································ 419

[표Ⅺ-79] 새로운 DDS 제제의 개발과 이를 이용한 제품 개발: 단백질소재 바이오신약 생체 달시스템을

이용한 암 이 억제제(CP-Nm23) 개발 상용화 개발 사업 개요 ··········································· 421

[표Ⅺ-80] 녹색성장을 한 고농도Biosolid를 이용한 바이오에 지 생산 진 기술개발 사업 개요 ············· 421

[표Ⅺ-81] 바이오가스 고순도메탄 정제 기술 개발 사업 개요 ····························································· 422

[표Ⅺ-82] 농산 바이오매스 폐기물을 이용한 자동차용 Trunk System 부품개발 사업 개요 ······················ 422

[표Ⅺ-83] 뇌졸 환자의 바이오 피드백 운동치료 기술개발 사업 개요 ··················································· 423

[표Ⅺ-84] 바이오가스의 고순도 정제를 한 분리막 공정 개발 사업 개요 ·········································· 423

[표Ⅺ-85] 합성가스 개질기용 바이오매스 폐기물 가스화로 설계 제작 기술개발 사업 개요 ·················· 424

[표Ⅺ-86] 고온 기소화 음식물쓰 기 탈리액의 바이오가스화 기술 개발 사업 개요 ······························· 424

[표Ⅺ-87] 미량 바이오 시료 분석용 다채 분 분석기 개발 사업 개요 ················································ 425

[표Ⅺ-88] 폐자재 바이오 고형연료를 이용한 소형 펠렛 제조 시스템 개발 사업 개요 ·························· 426

[표Ⅺ-89] 이 스캐 기반 고감도 바이오칩 진단기 개발 사업 개요 ·················································· 426

[표Ⅺ-90] 치아우식증 방을 한 로바이오틱 유산균 한방생약소재의 산업화 기술개발 사업개요 ··· 427

[표Ⅺ-91] 감귤박과 가축분뇨의 혼합 원료를 이용한 지역 바이오매스 맞춤형 기성 소화시스템

운 기술 개발 사업 개요 ····································································································· 428

[표Ⅺ-92] (S8007249) Remote Healthcare Monitoring System 개발 (바이오.의료) 사업 개요 ···················· 429

[표Ⅺ-93] 고부가가치 신기능성 바이오소재 (biomaterials) 생산 시스템의 고효율화 개발 사업 개요 ········· 429

[표Ⅺ-94] 바이오디젤 부산물을 이용한 로필 리콜 제조공정 기술개발 사업 개요 ····························· 430

[표Ⅺ-95] 산업폐수 슬러지 재활용 제고를 한 바이오매스 기반 펩타이드계 응집제 제조 기술개발 사업 개요

··········································································································································· 430

[표Ⅺ-96] 바이오피드백 제어형 외 자세지지 시 시스템 개발 사업 개요 ··············································· 431

[표Ⅺ-97] 당질계 바이오에탄올 생산을 한 응집성 효모 발효공정 개발 사업 개요 ··························· 431

[표Ⅺ-98] 과당화 기술을 이용한 알 -1 안티트립신 바이오베터 개발 사업 개요 ····································· 432

[표Ⅺ-99] 바이오 마커 코 스트립 제조 공정 시스템 개발 사업 개요 ··················································· 432

[표Ⅺ-100] 편백나무로부터 항여드름균, 항비듬균, 항무좀균활성 미백기능성 바이오소재개발사업개요 ···· 433

[표Ⅺ-101] 속 방사능 원소 90% 이상 제거 가능한 자원순환형 친환경 바이오필터 개발사업개요 ·· 433

[표Ⅺ-102] 로바이오틱 유산균 활용, 발효 기술을 이용한 마(산약)의 다이어트 련 기능성화 식품개발

사업 개요 ··························································································································· 433

20 한국산업마 연구소

[표Ⅺ-103] 고해상도 바이오 메디컬 이미징을 한 형 공 미경 개발 사업 개요 ·························· 434

[표Ⅺ-104] N-말단기 치특이 페길 이션 기술을 활용한 바이오베터 개발 (VEGF-Trap) 사업 개요 ··· 435

[표Ⅺ-105] 상온유통이 가능한 바이오의약품(단백질, 항체) 약물 달 랫폼 개발 사업 개요 ··············· 436

21 www.kimr.co.kr

그림 목차2012 바이오산업 분야별 시장동향과 유망기술 개발전략

Ⅰ. 바이오산업 동향 ··········································································· 31[그림Ⅰ-1] 바이오산업 분류 ········································································································31

[그림Ⅰ-2] 바이오산업 시장 규모 (단 : 백만원) ··································································32

[그림Ⅰ-3] 바이오산업 분야별 시장 유율 (단 : 백만원) ··················································33

[그림Ⅰ-4] 바이오산업 분야별 포지셔닝 - 2010년 ································································35

[그림Ⅰ-5] 바이오산업 분야별 국내 매 유율 (단 : 백만원) ······································36

[그림Ⅰ-6] 바이오산업 분야별 국내시장 포지셔닝 - 2010년 ··············································38

[그림Ⅰ-7] 바이오산업 분야별 수출 유율 (단 : 백만원) ················································39

[그림Ⅰ-8] 바이오산업 분야별 수출 포지셔닝 - 2010년 ······················································40

[그림Ⅰ-9] 바이오산업 분야별 수입 유율 (단 : 백만원) ················································41

[그림Ⅰ-10] 바이오산업 분야별 수입 포지셔닝 - 2010년 ····················································43

Ⅱ. 바이오의약산업 동향 ··································································· 47[그림Ⅱ-1] 바이오의약산업 분류 ································································································47

[그림Ⅱ-2] 바이오의약품 시장 규모 (단 : 백만원) ······························································50

[그림Ⅱ-3] 바이오의약품 분야별 시장 유율 (단 : 백만원) ··············································51

[그림Ⅱ-4] 바이오의약품 시장 분야별 포지셔닝 - 2010년 ··················································53

[그림Ⅱ-5] 바이오의약품 분야별 국내 매 유율 (단 : 백만원) ··································53

[그림Ⅱ-6] 바이오의약품 분야별 국내 매 포지셔닝 - 2010년 ········································55

[그림Ⅱ-7] 바이오의약품 분야별 수출 유율 (단 : 백만원) ············································56

[그림Ⅱ-8] 바이오의약품 분야별 수출 포지셔닝 - 2010년 ··················································58

[그림Ⅱ-9] 바이오의약품 분야별 수입 유율 (단 : 백만원) ············································58

[그림Ⅱ-10] 바이오의약품 분야별 수입 포지셔닝 - 2010년 ················································60

[그림Ⅱ-11] 항생제 시장 규모 (단 : 백만원) ········································································61

[그림Ⅱ-12] 항생제 시장 연도별 포지셔닝 ··············································································62

[그림Ⅱ-13] 항암제 시장 규모 (단 : 백만원) ········································································63

[그림Ⅱ-14] 항암제 시장 연도별 포지셔닝 ··············································································64

[그림Ⅱ-15] 백신 시장 규모 (단 : 백만원) ············································································65

[그림Ⅱ-16] 백신 시장 연도별 포지셔닝 ··················································································66

[그림Ⅱ-17] 호르몬제 시장 규모 (단 : 백만원) ····································································67

[그림Ⅱ-18] 호르몬제 시장 연도별 포지셔닝 ··········································································68

[그림Ⅱ-19] 면역제제 시장 규모 (단 : 백만원) ····································································69

22 한국산업마 연구소

[그림Ⅱ-20] 면역제제 시장 연도별 포지셔닝 ··········································································70

[그림Ⅱ-21] 액제제 시장 규모 (단 : 백만원) ····································································71

[그림Ⅱ-22] 액제제 시장 연도별 포지셔닝 ··········································································72

[그림Ⅱ-23] 성장인자 시장 규모 (단 : 백만원) ····································································73

[그림Ⅱ-24] 성장인자 시장 연도별 포지셔닝 ··········································································74

[그림Ⅱ-25] 신개념치료제 시장 규모 (단 : 백만원) ····························································75

[그림Ⅱ-26] 신개념치료제 시장 연도별 포지셔닝 ··································································76

[그림Ⅱ-27] 진단키트 시장 규모 (단 : 백만원) ····································································77

[그림Ⅱ-28] 진단키트 시장 연도별 포지셔닝 ··········································································78

[그림Ⅱ-29] 동물약품 시장 규모 (단 : 백만원) ····································································79

[그림Ⅱ-30] 동물약품 시장 연도별 포지셔닝 ··········································································80

[그림Ⅱ-31] 기타 바이오의약품 시장 연도별 포지셔닝 ························································81

Ⅲ. 바이오화학산업 동향 ··································································· 85[그림Ⅲ-1] 바이오화학산업 분류 ································································································85

[그림Ⅲ-2] 바이오화학 시장 규모 (단 : 백만원) ··································································88

[그림Ⅲ-3] 바이오화학 분야별 시장 유율 (단 : 백만원) ··················································89

[그림Ⅲ-4] 바이오화학 시장 분야별 포지셔닝 - 2010년 ······················································91

[그림Ⅲ-5] 바이오화학 분야별 국내 매 유율 (단 : 백만원) ······································91

[그림Ⅲ-6] 바이오화학 분야별 국내 매 포지셔닝 - 2010년 ············································93

[그림Ⅲ-7] 바이오화학 분야별 수출 유율 (단 : 백만원) ················································94

[그림Ⅲ-8] 바이오화학 분야별 수출 포지셔닝 - 2010년 ······················································95

[그림Ⅲ-9] 바이오화학 분야별 수입 유율 (단 : 백만원) ················································96

[그림Ⅲ-10] 바이오화학 분야별 수입 포지셔닝 - 2010년 ····················································98

[그림Ⅲ-11] 바이오고분자 시장 규모 (단 : 백만원) ····························································99

[그림Ⅲ-12] 바이오고분자 시장 연도별 포지셔닝 ································································100

[그림Ⅲ-13] 산업용효소 시약류 시장 규모 (단 : 백만원) ··········································101

[그림Ⅲ-14] 산업용효소 시약류 시장 연도별 포지셔닝 ················································102

[그림Ⅲ-15] 연구실험용 효소 시약류 시장 규모 (단 : 백만원) ································103

[그림Ⅲ-16] 연구실험용 효소 시약류 시장 연도별 포지셔닝 ······································104

[그림Ⅲ-17] 바이오화장품 생활화학제품 시장 규모 (단 : 백만원) ··························105

[그림Ⅲ-18] 바이오화장품 생활화학제품 시장 연도별 포지셔닝 ································106

[그림Ⅲ-19] 바이오농약 비료 시장 규모 (단 : 백만원) ··············································107

[그림Ⅲ-20] 바이오농약 비료 시장 연도별 포지셔닝 ····················································108

[그림Ⅲ-21] 기타 바이오화학제품 시장 규모 (단 : 백만원) ············································109

[그림Ⅲ-22] 기타 바이오화학제품 시장 연도별 포지셔닝 ··················································110

Ⅳ. 바이오식품산업 동향 ································································· 113[그림Ⅳ-1] 바이오식품산업 분류 ······························································································113

[그림Ⅳ-2] 바이오식품 시장 규모 (단 : 백만원) ································································116

23 www.kimr.co.kr

[그림Ⅳ-3] 바이오식품 분야별 시장 유율 (단 : 백만원) ················································117

[그림Ⅳ-4] 바이오식품 시장 분야별 포지셔닝 - 2010년 ····················································118

[그림Ⅳ-5] 바이오식품 분야별 국내 매 유율 (단 : 백만원) ····································119

[그림Ⅳ-6] 바이오식품 분야별 국내 매 포지셔닝 - 2010년 ··········································121

[그림Ⅳ-7] 바이오식품 분야별 수출 유율 (단 : 백만원) ··············································121

[그림Ⅳ-8] 바이오식품 분야별 수출 포지셔닝 - 2010년 ····················································123

[그림Ⅳ-9] 바이오식품 분야별 수입 유율 (단 : 백만원) ··············································123

[그림Ⅳ-10] 바이오식품 분야별 수입 포지셔닝 - 2010년 ··················································125

[그림Ⅳ-11] 건강기능식품 시장 규모 (단 : 백만원) ··························································126

[그림Ⅳ-12] 건강기능식품 시장 연도별 포지셔닝 ································································127

[그림Ⅳ-13] 아미노산 시장 규모 (단 : 백만원) ··································································128

[그림Ⅳ-14] 아미노산 시장 연도별 포지셔닝 ········································································129

[그림Ⅳ-15] 식품첨가물 시장 규모 (단 : 백만원) ······························································130

[그림Ⅳ-16] 식품첨가물 시장 연도별 포지셔닝 ····································································131

[그림Ⅳ-17] 발효식품 시장 규모 (단 : 백만원) ··································································132

[그림Ⅳ-18] 발효식품 시장 연도별 포지셔닝 ········································································133

[그림Ⅳ-19] 사료첨가제 시장 규모 (단 : 백만원) ······························································134

[그림Ⅳ-20] 사료첨가제 시장 연도별 포지셔닝 ····································································135

[그림Ⅳ-21] 기타 바이오식품 시장 규모 (단 : 백만원) ····················································136

[그림Ⅳ-22] 기타 바이오식품 시장 연도별 포지셔닝 ··························································137

Ⅴ.바이오환경산업 동향 ··································································· 141[그림Ⅴ-1] 바이오환경산업 분류 ······························································································141

[그림Ⅴ-2] 바이오환경 시장 규모 (단 : 백만원) ································································144

[그림Ⅴ-3] 바이오환경 분야별 시장 유율 (단 : 백만원) ················································145

[그림Ⅴ-4] 바이오환경 시장 분야별 포지셔닝 - 2010년 ····················································147

[그림Ⅴ-5] 바이오환경 분야별 국내 매 유율 (단 : 백만원) ····································147

[그림Ⅴ-6] 바이오환경 분야별 국내 매 포지셔닝 - 2010년 ··········································149

[그림Ⅴ-7] 바이오환경 분야별 수출 유율 (단 : 백만원) ··············································150

[그림Ⅴ-8] 바이오환경 분야별 수출 포지셔닝 - 2010년 ····················································151

[그림Ⅴ-9] 바이오환경 분야별 수입 유율 (단 : 백만원) ··············································152

[그림Ⅴ-10] 바이오환경 분야별 수입 포지셔닝 - 2010년 ··················································153

[그림Ⅴ-11] 환경처리용 미생물제제 시장 규모 (단 : 백만원) ········································154

[그림Ⅴ-12] 환경처리용 미생물제제 시장 연도별 포지셔닝 ··············································155

[그림Ⅴ-13] 미생물 고정화소재 설비 시장 규모 (단 : 백만원) ································156

[그림Ⅴ-14] 미생물 고정화소재 설비 시장 연도별 포지셔닝 ······································157

[그림Ⅴ-15] 바이오환경제제 시스템 시장 규모 (단 : 백만원) ··································158

[그림Ⅴ-16] 바이오환경제제 시스템 시장 연도별 포지셔닝 ········································159

[그림Ⅴ-17] 환경오염 측정시스템 시장 규모 (단 : 백만원) ············································160

[그림Ⅴ-18] 환경오염 측정시스템 시장 연도별 포지셔닝 ··················································161

[그림Ⅴ-19] 기타 바이오환경제품 서비스 시장 규모 (단 : 백만원) ························162

24 한국산업마 연구소

[그림Ⅴ-20] 기타 바이오환경제품 서비스 시장 연도별 포지셔닝 ······························163

Ⅵ. 바이오전자산업 동향 ································································· 167[그림Ⅵ-1] 바이오 자산업 분류 ······························································································167

[그림Ⅵ-2] 바이오 자 시장 규모 (단 : 백만원) ································································170

[그림Ⅵ-3] 바이오 자 분야별 시장 유율 (단 : 백만원) ················································171

[그림Ⅵ-4] 바이오 자 시장 분야별 포지셔닝 - 2010년 ····················································172

[그림Ⅵ-5] 바이오 자 분야별 국내 매 유율 (단 : 백만원) ····································173

[그림Ⅵ-6] 바이오 자 분야별 국내 매 포지셔닝 - 2010년 ··········································174

[그림Ⅵ-7] 바이오 자 분야별 수출 유율 (단 : 백만원) ··············································175

[그림Ⅵ-8] 바이오 자 분야별 수출 포지셔닝 - 2010년 ····················································176

[그림Ⅵ-9] 바이오 자 분야별 수입 유율 (단 : 백만원) ··············································177

[그림Ⅵ-10] 바이오 자 분야별 수입 포지셔닝 - 2010년 ··················································178

[그림Ⅵ-11] DNA칩 시장 규모 (단 : 백만원) ·····································································179

[그림Ⅵ-12] DNA칩 시장 연도별 포지셔닝 ···········································································180

[그림Ⅵ-13] 단백질칩 시장 규모 (단 : 백만원) ··································································181

[그림Ⅵ-14] 단백질칩 시장 연도별 포지셔닝 ········································································182

[그림Ⅵ-15] 세포칩 시장 규모 (단 : 백만원) ······································································182

[그림Ⅵ-16] 세포칩 시장 연도별 포지셔닝 ············································································183

[그림Ⅵ-17] 바이오센서 시장 규모 (단 : 백만원) ······························································184

[그림Ⅵ-18] 바이오센서 시장 연도별 포지셔닝 ····································································185

[그림Ⅵ-19] 바이오멤스 시장 규모 (단 : 백만원) ······························································186

[그림Ⅵ-20] 바이오멤스 시장 연도별 포지셔닝 ····································································187

[그림Ⅵ-21] 기타바이오 자제품 시장 규모 (단 : 백만원) ··············································188

[그림Ⅵ-22] 기타바이오 자제품 시장 연도별 포지셔닝 ····················································189

Ⅶ. 바이오공정 및 기기산업 동향 ················································· 193[그림Ⅶ-1] 바이오공정 기기산업 분류 ··············································································193

[그림Ⅶ-2] 바이오공정 기기 시장 규모 (단 : 백만원) ················································196

[그림Ⅶ-3] 바이오공정 기기 분야별 시장 유율 (단 : 백만원) ································197

[그림Ⅶ-4] 바이오공정 기기 시장 분야별 포지셔닝 - 2010년 ····································198

[그림Ⅶ-5] 바이오공정 기기 분야별 국내 매 유율 (단 : 백만원) ····················199

[그림Ⅶ-6] 바이오공정 기기 분야별 국내 매 포지셔닝 - 2010년 ··························201

[그림Ⅶ-7] 바이오공정 기기 분야별 수출 유율 (단 : 백만원) ······························201

[그림Ⅶ-8] 바이오공정 기기 분야별 수출 포지셔닝 - 2010년 ····································203

[그림Ⅶ-9] 바이오공정 기기 분야별 수입 유율 (단 : 백만원) ······························203

[그림Ⅶ-10] 바이오공정 기기 분야별 수입 포지셔닝 - 2010년 ··································205

[그림Ⅶ-11] 바이오반응기 시장 규모 (단 : 백만원) ··························································206

[그림Ⅶ-12] 바이오반응기 시장 연도별 포지셔닝 ································································207

[그림Ⅶ-13] 생체의료기기 진단기 시장 규모 (단 : 백만원) ······································208

25 www.kimr.co.kr

[그림Ⅶ-14] 생체의료기기 진단기 시장 연도별 포지셔닝 ············································209

[그림Ⅶ-15] 바이오공정 분석기기 시장 규모 (단 : 백만원) ······································210

[그림Ⅶ-16] 바이오공정 분석기기 시장 연도별 포지셔닝 ············································211

[그림Ⅶ-17] 공장 공정설계 시장 규모 (단 : 백만원) ··················································212

[그림Ⅶ-18] 공장 공정설계 시장 연도별 포지셔닝 ························································213

[그림Ⅶ-19] 기타 바이오공정 기기 시장 규모 (단 : 백만원) ····································214

[그림Ⅶ-20] 기타 바이오공정 기기 시장 연도별 포지셔닝 ··········································215

Ⅷ. 바이오에너지 및 자원산업 동향 ············································· 219[그림Ⅷ-1] 바이오에 지 자원산업 분류 ··········································································219

[그림Ⅷ-2] 바이오에 지 자원 시장 규모 (단 : 백만원) ············································222

[그림Ⅷ-3] 바이오에 지 자원 분야별 시장 유율 (단 : 백만원) ····························223

[그림Ⅷ-4] 바이오에 지 자원 시장 분야별 포지셔닝 - 2010년 ································224

[그림Ⅷ-5] 바이오에 지 자원 분야별 국내 매 유율 (단 : 백만원) ················225

[그림Ⅷ-6] 바이오에 지 자원 분야별 국내 매 포지셔닝 - 2010년 ······················227

[그림Ⅷ-7] 바이오에 지 자원 분야별 수출 유율 (단 : 백만원) ··························227

[그림Ⅷ-8] 바이오에 지 자원 분야별 수출 포지셔닝 - 2010년 ································228

[그림Ⅷ-9] 바이오에 지 자원 분야별 수입 유율 (단 : 백만원) ··························229

[그림Ⅷ-10] 바이오에 지 자원 분야별 수입 포지셔닝 - 2010년 ······························230

[그림Ⅷ-11] 바이오연료 시장 규모 (단 : 백만원) ······························································231

[그림Ⅷ-12] 바이오연료 시장 연도별 포지셔닝 ····································································232

[그림Ⅷ-13] 인공종자 묘목 시장 규모 (단 : 백만원) ··················································233

[그림Ⅷ-14] 인공종자 묘목 시장 연도별 포지셔닝 ························································234

[그림Ⅷ-15] 실험동물 시장 규모 (단 : 백만원) ··································································235

[그림Ⅷ-16] 실험동물 시장 연도별 포지셔닝 ········································································236

[그림Ⅷ-17] 유 자변형 동식물 시장 규모 (단 : 백만원) ················································237

[그림Ⅷ-18] 유 자변형 동식물 시장 연도별 포지셔닝 ······················································238

[그림Ⅷ-19] 기타 바이오에 지 자원 시장 규모 (단 : 백만원) ································238

Ⅸ. 바이오검정, 정보서비스, 연구개발산업 동향 ······················· 243[그림Ⅸ-1] 바이오검정, 정보서비스 연구개발 산업 분류 ·············································243

[그림Ⅸ-2] 바이오검정, 정보서비스 연구개발 사업 시장 규모 (단 : 백만원) ······· 246

[그림Ⅸ-3] 바이오검정, 정보서비스 연구개발 분야별 시장 유율 (단 : 백만원) · 247

[그림Ⅸ-4] 바이오검정, 정보서비스 연구개발품 시장 분야별 포지셔닝 - 2010년 · 249

[그림Ⅸ-5] 바이오검정, 정보서비스 연구개발 분야별 국내 매 유율 (단 : 백만원) ··········· 250

[그림Ⅸ-6] 바이오검정, 정보서비스 연구개발 분야별 국내 매 포지셔닝 - 2010년 ·· 252

[그림Ⅸ-7] 바이오검정, 정보서비스 연구개발 분야별 수출 유율 (단 : 백만원) 253

[그림Ⅸ-8] 바이오검정, 정보서비스 연구개발 분야별 수출 포지셔닝 - 2010년 ····· 254

[그림Ⅸ-9] 바이오검정, 정보서비스 연구개발 분야별 수입 유율 (단 : 백만원) 255

[그림Ⅸ-10] 바이오검정, 정보서비스 연구개발 분야별 수입 포지셔닝 - 2010년 ··· 256

26 한국산업마 연구소

[그림Ⅸ-11] 바이오정보 서비스 시장 규모 (단 : 백만원) ················································257

[그림Ⅸ-12] 바이오정보 서비스 시장 연도별 포지셔닝 ······················································258

[그림Ⅸ-13] 유 자 련 분석서비스 시장 규모 (단 : 백만원) ········································259

[그림Ⅸ-14] 유 자 련 분석서비스 시장 연도별 포지셔닝 ··············································260

[그림Ⅸ-15] 단백질 련 분석서비스 시장 규모 (단 : 백만원) ········································261

[그림Ⅸ-16] 단백질 련 분석서비스 시장 연도별 포지셔닝 ··············································262

[그림Ⅸ-17] 연구개발 서비스 시장 규모 (단 : 백만원) ····················································263

[그림Ⅸ-18] 연구개발 서비스 시장 연도별 포지셔닝 ··························································264

[그림Ⅸ-19] 바이오안정성 생리활성평가서비스 시장 규모 (단 : 백만원) ··············265

[그림Ⅸ-20] 바이오안정성 생리활성평가서비스 시장 연도별 포지셔닝 ····················266

[그림Ⅸ-21] 진단 보 서비스 시장 규모 (단 : 백만원) ··············································267

[그림Ⅸ-22] 진단 보 서비스 시장 연도별 포지셔닝 ····················································268

[그림Ⅸ-23] 기타 바이오검정, 정보개발서비스 연구개발 시장 규모 (단 : 백만원) ···· 269

[그림Ⅸ-24] 기타 바이오검정, 정보개발서비스 연구개발 시장 연도별 포지셔닝 ··· 270

Ⅹ. 유망 바이오시장 및 기술개발 동향 ······································· 273[그림Ⅹ-1] 바이오산업 시장 규모 망 (단 : 억원) ··························································273

[그림Ⅹ-2] 바이오산업 분야별 시장 규모 유율 망 - 2012년 (단 : 억원, %) 274

[그림Ⅹ-3] 바이오산업 분야별 포지셔닝 망 - 2012년 ····················································277

[그림Ⅹ-4] 유망 바이오 분야 선정 ··························································································278

[그림Ⅹ-5] 바이오매스에 지 분야 특허 출원동향 ······························································279

[그림Ⅹ-6] 바이오매스에 지 분야 특허 국내 출원동향 ····················································280

[그림Ⅹ-7] 바이오매스에 지 분야 국내 주요 출원인의 특허 출원 황 ······················280

[그림Ⅹ-8] 바이오의약품 분야 특허 출원동향 ······································································297

[그림Ⅹ-9] 바이오의약품 분야 특허 국내 출원동향 ····························································297

[그림Ⅹ-10] 바이오의약품 분야 국내 주요 출원인의 특허 출원 황 ····························298

[그림Ⅹ-11] 바이오자원, 신소재, 장기 분야 특허 출원동향 ···············································315

[그림Ⅹ-12] 바이오자원, 신소재, 장기 분야 특허 국내 출원동향 ·····································316

[그림Ⅹ-13] 바이오자원, 신소재, 장기 분야 국내 주요 출원인의 특허 출원 황 ·······316

[그림Ⅹ-14] 메디-바이오진단 시스템 분야 특허 출원동향 ················································329

[그림Ⅹ-15] 메디-바이오진단 시스템 분야 특허 국내 출원동향 ······································330

[그림Ⅹ-16] 메디-바이오진단 시스템 분야 국내 주요 출원인의 특허 출원 황 ········ 330

[그림Ⅹ-17] 고령친화 의료기기 분야 특허 출원동향 ··························································342

[그림Ⅹ-18] 고령친화 의료기기 분야 특허 국내 출원동향 ················································342

[그림Ⅹ-19] 고령친화 의료기기 분야 국내 주요 출원인의 특허 출원 황 ··················343

[그림Ⅹ-20] 첨단 상진단기기 분야 특허 출원동향 ····························································355

[그림Ⅹ-21] 첨단 상진단기기 분야 특허 국내 출원동향 ··················································356

[그림Ⅹ-22] 첨단 상진단기기 분야 국내 주요 출원인의 특허 출원 황 ····················356

27 www.kimr.co.kr

Ⅺ. 부록 - 유망 바이오 기술 개발 현황 ····································· 369[그림Ⅺ-1] 바이오디젤 기술개발 로드맵 ················································································369

[그림Ⅺ-2] 바이오에탄올 기술개발 로드맵 ············································································370

[그림Ⅺ-3] 바이오매스가스 기술개발 로드맵 ········································································371

[그림Ⅺ-4] 유 자 재조합 의약품 기술개발 로드맵 ····························································372

[그림Ⅺ-5] 세포치료제 기술개발 로드맵 ················································································373

[그림Ⅺ-6] 개량신약 기술개발 로드맵 ····················································································374

[그림Ⅺ-7] 천연물의약품 기술개발 로드맵 ············································································375

[그림Ⅺ-8] 바이오화장품 소재 기술개발 로드맵 ··································································376

[그림Ⅺ-9] 의료용 생체유래소재 기술개발 로드맵 ······························································377

[그림Ⅺ-10] 친환경농업소재 기술개발 로드맵 ······································································378

[그림Ⅺ-11] 소형 감염성 질환 만성질환 진단기 기술개발 로드맵 ····························380

[그림Ⅺ-12] 표 지향 진단 치료용 소재 기술개발 로드맵 ········································381

[그림Ⅺ-13] 재활 물리치료기기 기술개발 로드맵 ··························································382

[그림Ⅺ-14] 인체기능 치제품 기술개발 로드맵 ································································383

[그림Ⅺ-15] 이동지원기기 기술개발 로드맵 ··········································································384

[그림Ⅺ-16] 생체신호계측기기 기술개발 로드맵 ··································································385

[그림Ⅺ-17] 유방암 상진단기기 기술개발 로드맵 ····························································387

[그림Ⅺ-18] 음 상진단기기 기술개발 로드맵 ····························································388

[그림Ⅺ-19] 치과용 상진단기기 기술개발 로드맵 ····························································389